Guião
Guião
-------------------------------------------------------------------------------------------------------------------
Objectives: The main goal of this experimental work is to identify the subtypes of CAFs,
at the cellular and functional level, and understand their role in the TME.
-------------------------------------------------------------------------------------------------------------------
Methods
We will use breast carcinoma cells. In the first place, we perform a Fluorescence-
activated cell sorting to have a specific cell population (CAFs).
FACS is a specialized type of flow cytometry that provides a method for sorting a
heterogeneous mixture of biological cells into containers, one cell at a time, based upon
the specific light scattering and fluorescent characteristics of each cell.
-------------------------------------------------------------------------------------------------------------------
How FACS works?
Very briefly, the cell suspension is dragged in the center of a narrow, rapidly flowing
stream of liquid. The flow is arranged so that there is a large separation between cells
relative to their diameter. Then, a vibrating mechanism causes the stream of cells to
break into individual droplets. The flow passes through a fluorescence measuring station
where the fluorescent character of interest of each cell is measured.
This fluorescence is obtained when we add to the cell suspension antibody specific for a
particular cell surface protein associated to a fluorescent molecule.
(https://www.sinobiological.com/category/fcm-facs-facs)
To obtain only CAFs, we will perfume a negative selection, where we will select cells that
are negative for these markers: EpCAM-/CD45-/CD31-/NG2. With this, we don’t select
epithelial cells, immune cells, endothelial cells and pericytes.
-------------------------------------------------------------------------------------------------------------------
After we have CAFs isolated, we perform a Single-cell RNA sequencing, where we
analyze the gene expression and can elucidate what genes are expressed by CAFs.
-------------------------------------------------------------------------------------------------------------------
How Single-cell RNA sequencing works?
Single-cell RNA sequencing provides transcriptional profiling of thousands of individuals
cells, which enables us to understand at the single-cell level what genes are expressed,
in what quantities, and how they differ across thousands of cells within a heterogeneous
sample.
Firstly, and after we isolate cells, we do cDNA using reverse transcription. Then, we
amplify cDNA by PCR and procced for the library preparation and consequently, we
sequence these libraries (via Next Generation Sequencing). Lastly, we perform
bioinformatic analyses.
Library is a collection of similarly sized DNA fragments with known adapter sequencer
added to the 5’ and 3’ ends.
After we know what genes are expressed in CAFs, we follow to study the function of
each subtype.
-------------------------------------------------------------------------------------------------------------------
To do this, we use a 3D microfluid platform (3D microfluid Cancer Microenvironment),
where we will do independent experiments for each subtype. A microfluidic device
consisted of four injection ports for filling collagen gel, a pair of side channels for driving
interstitial flow, and one central channel for loading cells (cancer cells and CAFs). The
interior of the channels is coated with ECM proteins for cell adhesion.
To study angiogenesis, we add the vascular endothelial growth factor (VEGF), and we
analyze it through confocal microscopy. However, we can collect the medium or cells in
channel to perform biochemical or PCR analysis.[2]
However, to study tumor migration, we first inject HUVECs for 2 days to allow the
formation of an endothelial monolayer in the central channel. Then we inject cancer
cells with CAFs. After 2 days, we count the number of cancer cells in the collagen gel
(invasive cell number), measure the area of propagated cells (invaded area) and
measure the maximum distance traveled from the primary site (penetrated distance).
-------------------------------------------------------------------------------------------------------------------
To do this, we do immunostaining, where we stained the CAF and the actin filaments
(Fibroblast-specific protein-1 antibody or anti-vimentin antibody or anti-alpha smooth
muscle actin antibody; Phalloidin-tetramethylrhodamine B isothiocyanate). We stained
the nuclei with DAPI.
The heterogeneity of the origin, phenotype, and function of CAFs poses a challenge to
the current research on CAFs.
However, the plasticity of CAFs offers promise concerning immunotherapy and targeted
therapy. Based on the aforementioned challenges and directions, researchers should
perform a multidirectional and multidimensional study on CAFs, discover specific
biomarkers of CAFs and corresponding targeted treatments, and explore the interaction
mechanisms between CAFs, tumor cells, immune cells, and other components of the
TME. These investigations may result in breakthroughs in the methods used for the
diagnosis, treatment, monitoring, and prevention of tumors.